Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Am Fam Physician ; 86(7): 643-9, 2012 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-23062092

RESUMO

Acute stress disorder is a psychiatric diagnosis that may occur in patients within four weeks of a traumatic event. Features include anxiety, intense fear or helplessness, dissociative symptoms, reexperiencing the event, and avoidance behaviors. Persons with this disorder are at increased risk of developing posttraumatic stress disorder. Other risk factors for posttraumatic stress disorder include current or family history of anxiety or mood disorders, a history of sexual or physical abuse, lower cognitive ability, engaging in excessive safety behaviors, and greater symptom severity one to two weeks after the trauma. Common reactions to trauma include physical, mental, and emotional symptoms. Persistent psychological distress that is severe enough to interfere with psychological or social functioning may warrant further evaluation and intervention. Patients experiencing acute stress disorder may benefit from psychological first aid, which includes ensuring the patient's safety; providing information about the event, stress reactions, and how to cope; offering practical assistance; and helping the patient to connect with social support and other services. Cognitive behavior therapy is effective in reducing symptoms and decreasing the future incidence of posttraumatic stress disorder. Critical Incident Stress Debriefing aims to mitigate emotional distress through sharing emotions about the traumatic event, providing education and tips on coping, and attempting to normalize reactions to trauma. However, this method may actually impede natural recovery by overwhelming victims. There is insufficient evidence to recommend the routine use of drugs in the treatment of acute stress disorder. Short-term pharmacologic intervention may be beneficial in relieving specific associated symptoms, such as pain, insomnia, and depression.


Assuntos
Papel do Médico , Transtornos de Estresse Traumático Agudo/terapia , Humanos , Fatores de Risco , Transtornos de Estresse Traumático Agudo/diagnóstico , Transtornos de Estresse Traumático Agudo/epidemiologia , Transtornos de Estresse Traumático Agudo/psicologia
3.
J Dent Educ ; 75(8): 1003-9, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21828293

RESUMO

The purpose of this study was to obtain information about education in substance use and dependence that appears in the predoctoral curricula of U.S. and Canadian dental schools. Sixty-eight deans were sent a twenty-item survey requesting information about when in the curriculum these subjects were taught, what instructional methods were used, and whether behavior change instruction was included to address these issues in clinical interactions. The survey had an 81 percent response rate. The topics of alcohol use and dependence, tobacco use and dependence, and prescription drug misuse and abuse were reported in over 90 percent (N=55) of responding schools' predoctoral curricula. The topic of other substance use and dependence was reported in only 72.7 percent (N=40) of these schools. The primary instructional method reported was the use of lecture. Less frequently used methods included small-group instruction, instruction in school-based clinic, community-based extramural settings, and independent study. As future health professionals, dental students are an important source for patients concerning substance use, abuse, and treatment. Our investigation confirmed that alcohol, tobacco, and prescription drug abuse is addressed widely in predoctoral dental curricula, but other substance use and dependence are less frequently addressed.


Assuntos
Terapia Comportamental/educação , Currículo , Educação em Odontologia , Faculdades de Odontologia/estatística & dados numéricos , Transtornos Relacionados ao Uso de Substâncias , Canadá , Competência Clínica , Coleta de Dados , Educação em Odontologia/métodos , Humanos , Estados Unidos
4.
Am Fam Physician ; 79(9): 785-91, 2009 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-20141098

RESUMO

Generalized anxiety disorder is common among patients in primary care. Affected patients experience excessive chronic anxiety and worry about events and activities, such as their health, family, work, and finances. The anxiety and worry are difficult to control and often lead to physiologic symptoms, including fatigue, muscle tension, restlessness, and other somatic complaints. Other psychiatric problems (e.g., depression) and nonpsychiatric factors (e.g., endocrine disorders, medication adverse effects, withdrawal) must be considered in patients with possible generalized anxiety disorder. Cognitive behavior therapy and the first-line pharmacologic agents, selective serotonin reuptake inhibitors, are effective treatments. However, evidence suggests that the effects of cognitive behavior therapy may be more durable. Although complementary and alternative medicine therapies have been used, their effectiveness has not been proven in generalized anxiety disorder. Selection of the most appropriate treatment should be based on patient preference, treatment success history, and other factors that could affect adherence and subsequent effectiveness.


Assuntos
Transtornos de Ansiedade/diagnóstico , Transtornos de Ansiedade/tratamento farmacológico , Escalas de Graduação Psiquiátrica Breve , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Transtornos de Ansiedade/terapia , Terapia Cognitivo-Comportamental , Terapias Complementares , Depressão/complicações , Humanos
5.
Am Fam Physician ; 74(7): 1159-64, 2006 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-17039753

RESUMO

Family physicians often treat patients who are experiencing psychological or medical crises. Any event perceived as overwhelming by the patient may trigger a crisis reaction consisting of psychological and physiological symptoms. Physicians are encouraged to assist patients who are experiencing a crisis by: (1) providing reassurance and support; (2) evaluating the nature of the problem and determining the patient's mental, psychiatric, suicidal or homicidal, and medical statuses; (3) ensuring the safety of the patient and others; (4) assisting the patient in developing an action plan that minimizes distress, and obtaining patient commitment to the plan; and (5) following up with the patient and other relevant persons to ensure follow-through, assess progress, and provide additional assistance and support. Medication or referral for psychiatric or psychological counseling may be necessary for patients with continuing problems.


Assuntos
Adaptação Psicológica , Estresse Psicológico/terapia , Humanos , Planejamento de Assistência ao Paciente , Papel do Médico , Guias de Prática Clínica como Assunto , Estresse Psicológico/etiologia
6.
Congest Heart Fail ; 9(3): 163-9, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12826775

RESUMO

The prevalence rates of depression in congestive heart failure patients range from 24%-42%. Depression is a graded, independent risk factor for readmission to the hospital, functional decline, and mortality in patients with congestive heart failure. Physicians can assess depression by using the SIG E CAPS + mood mnemonic, or any of a number of easily administered and scored self-report inventories. Cognitive-behavior therapy is the preferred psychological treatment. Cognitive-behavior therapy emphasizes the reciprocal interactions among physiology, environmental events, thoughts, and behaviors, and how these may be altered to produce changes in mood and behavior. Pharmacologically, the selective serotonin reuptake inhibitors are recommended, whereas the tricyclic antidepressants are not recommended for depression in congestive heart failure patients. The combination of a selective serotonin reuptake inhibitor with cognitive-behavior therapy is often the most effective treatment.


Assuntos
Depressão/epidemiologia , Insuficiência Cardíaca/epidemiologia , Antidepressivos/uso terapêutico , Terapia Cognitivo-Comportamental , Comorbidade , Depressão/tratamento farmacológico , Depressão/terapia , Interações Medicamentosas , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...